EUVIMEDEUVIMED entdecken
Open Access

Challenging the Boundaries Between Treatment, Prevention, and Enhancement in Human Genome Editing

Margaret Waltz iD, Rebecca L Walker, Michael A Flatt, Douglas MacKay, John M Conley, Eric T Juengst, R Jean Cadigan iD

The CRISPR Journal · 01.08.2024 · 7 (4) · 180-187

DOI: 10.1089/crispr.2024.0021 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The CRISPR Journal, online erschienen am 14.08.2024. Verfasst von Margaret Waltz und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Social Medicine and Center for Bioethics, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA. Hauptthemen laut MEDLINE: Gene Editing, Genome, Human. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHGRI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Traditional distinctions between treatment and enhancement goals for human genome editing (HGE) have animated oversight considerations, yet these categories have been complicated by the addition of prevention as a possible target for HGE applications. To assess the role these three categories might play in continued HGE governance efforts, we report on interviews with genome editing scientists and governance group members. While some accepted traditional distinctions between treatment and enhancement and rejected the latter as unacceptable, others argued that the concept of enhancement is largely irrelevant or not as morally problematic as suggested. Others described how preventive goals for HGE create gray zones where prevention and enhancement may be difficult to distinguish, which may stymie uses of HGE. We conclude by discussing the governance implications of these various understandings of treatment, prevention, and enhancement as HGE research moves beyond the treatment of serious disease to embrace longer range preventive goals.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gene EditingGenome, HumanHumansCRISPR-Cas SystemsGenetic Therapy

Autor:innen und Institutionen

  • Department of Social Medicine and Center for Bioethics, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
  • Department of Philosophy, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
  • Department of Sociology, Cuyahoga Community College, Cleveland, Ohio, USA.
  • Department of Public Policy and Center for Bioethics, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
  • School of Law, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.

ORCID-Profile: Margaret Waltz, R Jean Cadigan

Förderung

  • NHGRI NIH HHS

Zitieren

APA

Waltz, M., Walker, R. L., Flatt, M. A., MacKay, D., Conley, J. M., Juengst, E. T., & Cadigan, R. J. (2024). Challenging the Boundaries Between Treatment, Prevention, and Enhancement in Human Genome Editing. The CRISPR Journal, 7(4), 180-187. https://doi.org/10.1089/crispr.2024.0021

Vancouver

Waltz M, Walker RL, Flatt MA, MacKay D, Conley JM, Juengst ET, et al. Challenging the Boundaries Between Treatment, Prevention, and Enhancement in Human Genome Editing. The CRISPR Journal. 2024;7(4):180-187. doi:10.1089/crispr.2024.0021

BibTeX
@article{Waltz2024,
  author = {Waltz, Margaret and Walker, Rebecca L and Flatt, Michael A and MacKay, Douglas and Conley, John M and Juengst, Eric T and Cadigan, R Jean},
  title = {Challenging the Boundaries Between Treatment, Prevention, and Enhancement in Human Genome Editing},
  journal = {The CRISPR Journal},
  year = {2024},
  volume = {7},
  number = {4},
  pages = {180--187},
  doi = {10.1089/crispr.2024.0021}
}
Kostenlos starten →